• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用高通量微量肉汤生长抑制试验检测噬菌体对产碳青霉烯酶肺炎克雷伯菌分离株的裂解活性

Detection of Phage's Lytic Activity Against Carbapenemase-Producing Klebsiella pneumoniae Isolates Using a High-Throughput Microbroth Growth Inhibition Assay.

作者信息

Paranos Paschalis, Pournaras Spyros, Meletiadis Joseph

机构信息

Clinical Microbiology Laboratory, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Infect Dis Ther. 2025 Jan;14(1):217-228. doi: 10.1007/s40121-024-01092-0. Epub 2024 Dec 22.

DOI:10.1007/s40121-024-01092-0
PMID:39709574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11782791/
Abstract

INTRODUCTION

The host range of phages is usually assessed with the agar overlay method. However, this method is both cumbersome and subjective. Therefore, a microbroth assay was developed to assess host range and lytic activity patterns of phages in the agar overlay method against a collection of carbapenemase-producing Klebsiella pneumoniae (CRKP) isolates.

METHODS

The host range of 11 K. pneumoniae-specific phages against 8 non-repetitive well-characterized CRKP isolates was assessed with the agar overlay method and a microbroth assay by monitoring optical density (OD) at 630 nm for 24 h at different phage concentrations (5 × 10-5 × 10 PFU/ml) and two bacterial inocula (5 × 10 and 5 × 10 CFU/ml). The lytic activity of phage-bacteria pairs with transparent/semi-transparent (N = 7), turbid (N = 6), and no (N = 6) lysis in overlay agar method was compared statistically with the growth inhibition at 6 and 24 h in the microbroth assay with analysis of variance (ANOVA), receiver operating characteristic curves (ROC) curves and Fisher's exact test. Optimal cutoffs were determined, and sensitivity and specificity were calculated.

RESULTS

Statistically significant differences of growth inhibition at 6 and 24 h for phage concentrations ≥ 5 × 10 PFU/ml for both inocula were found between phages with transparent/semi-transparent, turbid, and no lysis. ROC curve analysis indicated an optimal growth inhibition cutoff of ≥ 31% at high phage and bacteria concentrations for detecting phages with lysis and ≥ 61% at high-phage and low-bacteria concentrations for detecting phages with transparent/semi-transparent lysis with sensitivity/specificity 100%/100% and 100%/86%, respectively.

CONCLUSIONS

The microbroth growth inhibition assay provided fast, reliable, and objective results for K. pneumoniae phage host-range lytic activity differentiating different patterns of lysis in a high-throughput format.

摘要

引言

噬菌体的宿主范围通常采用琼脂覆盖法进行评估。然而,该方法既繁琐又主观。因此,开发了一种微量肉汤测定法,以评估在琼脂覆盖法中噬菌体对一组产碳青霉烯酶肺炎克雷伯菌(CRKP)分离株的宿主范围和裂解活性模式。

方法

采用琼脂覆盖法和微量肉汤测定法,通过在不同噬菌体浓度(5×10 - 5×10 PFU/ml)和两种细菌接种量(5×10和5×10 CFU/ml)下监测630 nm处的光密度(OD)24小时,评估11种肺炎克雷伯菌特异性噬菌体对8株特征明确的非重复性CRKP分离株的宿主范围。对在覆盖琼脂法中呈现透明/半透明裂解(N = 7)、浑浊裂解(N = 6)和无裂解(N = 6)的噬菌体-细菌对的裂解活性,与微量肉汤测定法中6小时和24小时的生长抑制情况进行方差分析(ANOVA)、受试者工作特征曲线(ROC)分析和Fisher精确检验。确定最佳临界值,并计算敏感性和特异性。

结果

对于两种接种量,当噬菌体浓度≥5×10 PFU/ml时,在6小时和24小时的生长抑制方面,具有透明/半透明裂解、浑浊裂解和无裂解的噬菌体之间存在统计学显著差异。ROC曲线分析表明,在高噬菌体和细菌浓度下,检测有裂解的噬菌体的最佳生长抑制临界值≥31%,在高噬菌体和低细菌浓度下,检测有透明/半透明裂解的噬菌体的最佳生长抑制临界值≥61%,敏感性/特异性分别为100%/100%和100%/86%。

结论

微量肉汤生长抑制测定法为肺炎克雷伯菌噬菌体宿主范围裂解活性提供了快速、可靠且客观的数据,能够以高通量形式区分不同的裂解模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcab/11782791/1367dc249084/40121_2024_1092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcab/11782791/43e138b204ce/40121_2024_1092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcab/11782791/8953e70a6bcd/40121_2024_1092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcab/11782791/1367dc249084/40121_2024_1092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcab/11782791/43e138b204ce/40121_2024_1092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcab/11782791/8953e70a6bcd/40121_2024_1092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcab/11782791/1367dc249084/40121_2024_1092_Fig3_HTML.jpg

相似文献

1
Detection of Phage's Lytic Activity Against Carbapenemase-Producing Klebsiella pneumoniae Isolates Using a High-Throughput Microbroth Growth Inhibition Assay.使用高通量微量肉汤生长抑制试验检测噬菌体对产碳青霉烯酶肺炎克雷伯菌分离株的裂解活性
Infect Dis Ther. 2025 Jan;14(1):217-228. doi: 10.1007/s40121-024-01092-0. Epub 2024 Dec 22.
2
Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.从 COVID-19 患者呼吸机相关性肺炎(VAP)感染中分离的产碳青霉烯酶肺炎克雷伯菌(CRKP)中分离、鉴定、治疗效力及新型噬菌体 vB_KshKPC-M 的基因组分析。
Ann Clin Microbiol Antimicrob. 2023 Feb 24;22(1):18. doi: 10.1186/s12941-023-00567-1.
3
[Biological characteristics and genomic information of a bacteriophage against pan-drug resistant in a burn patient and its effects on bacterial biofilm].[烧伤患者中一株抗泛耐药菌噬菌体的生物学特性、基因组信息及其对细菌生物膜的影响]
Zhonghua Shao Shang Za Zhi. 2020 Jan 20;36(1):14-23. doi: 10.3760/cma.j.issn.1009-2587.2020.01.004.
4
Characterization and genome analysis of novel Klebsiella pneumoniae phage vbKpUKJ_2 isolated from hospital sewage water.从医院污水中分离出的新型肺炎克雷伯菌噬菌体vbKpUKJ_2的特性及基因组分析
BMC Microbiol. 2025 Feb 26;25(1):96. doi: 10.1186/s12866-025-03813-y.
5
Isolation and characterization of bacteriophage against clinical isolates of AmpC beta lactamase-Producing Klebsiella pneumoniae from hospital wastewater.从医院废水中分离和鉴定针对产AmpCβ-内酰胺酶肺炎克雷伯菌临床分离株的噬菌体。
PLoS One. 2025 Feb 21;20(2):e0315079. doi: 10.1371/journal.pone.0315079. eCollection 2025.
6
Characterization of ST11 Isolates and Their Interactions with Lytic Phages.ST11 分离株的特性及其与裂解噬菌体的相互作用。
Viruses. 2019 Nov 19;11(11):1080. doi: 10.3390/v11111080.
7
Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.裂解噬菌体对抗 ST11 K47 碳青霉烯类耐药肺炎克雷伯菌及其相应的噬菌体耐药机制。
mSphere. 2022 Apr 27;7(2):e0008022. doi: 10.1128/msphere.00080-22. Epub 2022 Mar 8.
8
A single-layer spot assay for easy, fast, and high-throughput quantitation of phages against multidrug-resistant Gram-negative pathogens.一种单层斑点分析检测法,可轻松、快速、高通量地定量检测针对多药耐药革兰氏阴性病原体的噬菌体。
J Clin Microbiol. 2024 Aug 14;62(8):e0074324. doi: 10.1128/jcm.00743-24. Epub 2024 Jul 29.
9
Diversity of lytic bacteriophages against XDR Klebsiella pneumoniae sequence type 16 recovered from sewage samples in different parts of the world.从世界不同地区污水样本中回收的针对广泛耐药肺炎克雷伯菌 16 型的裂解噬菌体的多样性。
Sci Total Environ. 2022 Sep 15;839:156074. doi: 10.1016/j.scitotenv.2022.156074. Epub 2022 May 24.
10
PHIDA: A High Throughput Turbidimetric Data Analytic Tool to Compare Host Range Profiles of Bacteriophages Isolated Using Different Enrichment Methods.PHIDA:一种高通量浊度数据分析工具,用于比较使用不同富集方法分离的噬菌体的宿主范围特征。
Viruses. 2021 Oct 21;13(11):2120. doi: 10.3390/v13112120.

引用本文的文献

1
Bacteriophage-Based Approach Against Biofilm Infections Associated with Medical Devices: A Narrative Review of ESKAPE Pathogens.基于噬菌体的医疗器械相关生物膜感染防治方法:对ESKAPE病原体的叙述性综述
Int J Mol Sci. 2025 Sep 6;26(17):8699. doi: 10.3390/ijms26178699.
2
Therapeutic application of a jumbo bacteriophage against metallo-β-lactamase producing Pseudomonas aeruginosa clinical isolates.一种巨型噬菌体对产金属β-内酰胺酶铜绿假单胞菌临床分离株的治疗应用。
J Biomed Sci. 2025 Aug 11;32(1):74. doi: 10.1186/s12929-025-01169-z.
3
In Vitro Interactions Between Bacteriophages and Antibacterial Agents of Various Classes Against Multidrug-Resistant Metallo-β-Lactamase-Producing Clinical Isolates.

本文引用的文献

1
Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections.噬菌体治疗的药代动力学和药效学:综述,重点关注多药耐药革兰氏阴性细菌感染。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0004424. doi: 10.1128/cmr.00044-24. Epub 2024 Jul 29.
2
A single-layer spot assay for easy, fast, and high-throughput quantitation of phages against multidrug-resistant Gram-negative pathogens.一种单层斑点分析检测法,可轻松、快速、高通量地定量检测针对多药耐药革兰氏阴性病原体的噬菌体。
J Clin Microbiol. 2024 Aug 14;62(8):e0074324. doi: 10.1128/jcm.00743-24. Epub 2024 Jul 29.
3
噬菌体与各类抗菌剂对产多重耐药金属β-内酰胺酶临床分离株的体外相互作用
Pharmaceuticals (Basel). 2025 Feb 27;18(3):343. doi: 10.3390/ph18030343.
Drivers and consequences of bacteriophage host range.
噬菌体宿主范围的驱动因素和后果。
FEMS Microbiol Rev. 2023 Jul 5;47(4). doi: 10.1093/femsre/fuad038.
4
L-form conversion in Gram-positive bacteria enables escape from phage infection.革兰氏阳性菌中的 L 型转换使其能够逃避噬菌体感染。
Nat Microbiol. 2023 Mar;8(3):387-399. doi: 10.1038/s41564-022-01317-3. Epub 2023 Jan 30.
5
Effects of KLDS1.0901 on Proliferation and Apoptosis of Colon Cancer Cells.KLDS1.0901对结肠癌细胞增殖和凋亡的影响
Front Microbiol. 2022 Feb 11;12:788040. doi: 10.3389/fmicb.2021.788040. eCollection 2021.
6
Independent host- and bacterium-based determinants protect a model symbiosis from phage predation.独立的宿主和细菌决定因素可保护模型共生体免受噬菌体捕食。
Cell Rep. 2022 Feb 15;38(7):110376. doi: 10.1016/j.celrep.2022.110376.
7
PHIDA: A High Throughput Turbidimetric Data Analytic Tool to Compare Host Range Profiles of Bacteriophages Isolated Using Different Enrichment Methods.PHIDA:一种高通量浊度数据分析工具,用于比较使用不同富集方法分离的噬菌体的宿主范围特征。
Viruses. 2021 Oct 21;13(11):2120. doi: 10.3390/v13112120.
8
In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.新型β-内酰胺酶抑制剂他尼硼巴坦与头孢吡肟或美罗培南对肺炎克雷伯菌的体外比较活性以及头孢吡肟对产金属β-内酰胺酶的铜绿假单胞菌临床分离株的体外比较活性。
Int J Antimicrob Agents. 2021 Nov;58(5):106440. doi: 10.1016/j.ijantimicag.2021.106440. Epub 2021 Sep 20.
9
Differential Bacteriophage Efficacy in Controlling in Cattle Hide and Soil Models.不同噬菌体在牛皮和土壤模型中控制[具体内容缺失]的效果
Front Microbiol. 2021 Jun 28;12:657524. doi: 10.3389/fmicb.2021.657524. eCollection 2021.
10
Phage Therapy: The Pharmacology of Antibacterial Viruses.噬菌体疗法:抗菌病毒的药理学
Curr Issues Mol Biol. 2021;40:81-164. doi: 10.21775/cimb.040.081. Epub 2020 Jun 6.